CFS Investment Advisory Services LLC Purchases 451 Shares of The Clorox Company (NYSE:CLX)

CFS Investment Advisory Services LLC lifted its holdings in The Clorox Company (NYSE:CLX) by 12.1% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 4,178 shares of the company’s stock after purchasing an additional 451 shares during the period. CFS Investment Advisory Services LLC’s holdings in Clorox were worth $679,000 as of its most recent filing with the SEC.

Other large investors have also made changes to their positions in the company. Brooklyn Investment Group lifted its holdings in shares of Clorox by 163.8% during the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock worth $25,000 after buying an additional 95 shares during the last quarter. Prospera Private Wealth LLC bought a new position in Clorox during the third quarter worth $27,000. Continuum Advisory LLC raised its stake in Clorox by 300.0% during the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock valued at $30,000 after purchasing an additional 138 shares during the last quarter. Quarry LP boosted its holdings in Clorox by 99.1% in the 2nd quarter. Quarry LP now owns 229 shares of the company’s stock valued at $31,000 after purchasing an additional 114 shares during the period. Finally, Carolina Wealth Advisors LLC bought a new position in shares of Clorox during the 3rd quarter worth about $48,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Stock Performance

NYSE CLX opened at $159.12 on Friday. The Clorox Company has a 1-year low of $127.60 and a 1-year high of $171.37. The company has a 50 day moving average of $163.66 and a 200-day moving average of $157.32. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08. The firm has a market cap of $19.70 billion, a price-to-earnings ratio of 55.44, a PEG ratio of 2.92 and a beta of 0.42.

Clorox (NYSE:CLX) last released its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, beating analysts’ consensus estimates of $1.36 by $0.50. The firm had revenue of $1.76 billion during the quarter, compared to analysts’ expectations of $1.64 billion. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The business’s revenue was up 27.0% on a year-over-year basis. During the same period last year, the firm posted $0.49 EPS. On average, equities analysts forecast that The Clorox Company will post 6.87 earnings per share for the current fiscal year.

Clorox Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be paid a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.07%. The ex-dividend date is Wednesday, January 29th. Clorox’s dividend payout ratio is presently 170.04%.

Analyst Ratings Changes

Several research firms recently weighed in on CLX. JPMorgan Chase & Co. increased their target price on shares of Clorox from $167.00 to $171.00 and gave the company a “neutral” rating in a research note on Thursday, January 16th. Jefferies Financial Group raised Clorox from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $174.00 to $187.00 in a report on Tuesday, October 1st. StockNews.com cut Clorox from a “buy” rating to a “hold” rating in a research report on Sunday, January 5th. Wells Fargo & Company raised Clorox from an “underweight” rating to an “equal weight” rating and raised their target price for the stock from $155.00 to $157.00 in a research report on Tuesday, January 7th. Finally, Barclays dropped their price objective on shares of Clorox from $139.00 to $130.00 and set an “underweight” rating for the company in a research note on Friday, January 17th. Four analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has issued a buy rating to the stock. According to MarketBeat, Clorox has a consensus rating of “Hold” and a consensus target price of $156.54.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.